Clinical Trials · NCT02793154
An Exploratory Study on the Effects of Repeat Doses of Albiglutide Compared to Exenatide on Gastric Myoelectrical Activity and Gastric Emptying in Type 2 Diabetes Mellitus Subjects
- Phase
- Phase 4
- Recruitment status
- Terminated
- Sponsor
- GlaxoSmithKline
- Enrollment
- 4
- Start date
- Sep 2016
- Locations
- 2 sites, United States
- Primary endpoint
- Part A: Distribution of Average Power by Frequency Region